KCAS

KCAS Bioanalytical and Biomarker Services Announces Growth to Scientific Leadership Team

Retrieved on: 
Tuesday, April 25, 2023
Research, General Health, Pharmaceutical, Data Management, Biometrics, Technology, Genetics, Science, Biotechnology, Other Technology, Other Science, Health, Georgia Tech, Drug development, University, Bureau of Oceans and International Environmental and Scientific Affairs, Senior, Q2, University of Valencia Science Park, Cellular, NEX Group, Infection, ATMP, Multimedia, History, Biomedical engineering, Assistant, PBMC, LIMS, Boehringer Ingelheim, Biomarker, Molecular biology, Eurofins Scientific, Flow cytometry, Biomedicine, KCAS, Immune system, Knowledge, ADC, Growth, Immunogenicity, INRS, Autoimmunity, Management, Fine chemical, Virology, Peptide

In addition, he will continue his role as a key member of our current operations integration team and the Senior Leadership Team.

Key Points: 
  • In addition, he will continue his role as a key member of our current operations integration team and the Senior Leadership Team.
  • “I look forward to this new opportunity to expand further the footprint of the bioanalytical and Biomarkers fields at KCAS.
  • As Executive Director, Cheikh will be responsible for the strategic leadership and management oversight of our Biopharma Services division, positioning the company for continued growth.
  • In addition, he will be an integral member of our global Integration strategy and will continue to be a member of the Senior Leadership Team.

KCAS Expands Its Transatlantic Presence with the Acquisition of France-based Active Biomarkers

Retrieved on: 
Monday, September 12, 2022
Biotechnology, Technology, Other Health, Health, Pharmaceutical, Oncology, Other Science, Other Technology, Research, Genetics, Science, MSD, Partner, Inflammation, PK, Vitruvian Partners, GLP, Infection, ELISA, Luminex, Neurodegeneration, Acquisition, Biomarker, Growth, Partnership, GCLP, Investment, CEO, CRO, BSL2, ELLA, Science, Drug development, KCAS, ISO 9001:2015, Multimedia, Flow cytometry, ISO, ELISpot, Fine chemical, Kansas City metropolitan area, Vitruvian Man

Active Biomarkers is a renowned assay development and specialty bioanalytical laboratory with expertise in oncology, infectious disease, inflammation and neurodegenerative disorders.

Key Points: 
  • Active Biomarkers is a renowned assay development and specialty bioanalytical laboratory with expertise in oncology, infectious disease, inflammation and neurodegenerative disorders.
  • The acquisition of Active Biomarkers is the second in 2022 by KCAS.
  • The acquisition of Active Biomarkers gives our combined clients access to further scientific expertise and support in both markets regionally and internationally.
  • The acquisition of Active Biomarkers by KCAS builds on the excellent foundation KCAS has built in the US and supports the increasingly international needs of the companys growing pharmaceutical and biotech clients.

Demand Gen Report Announces Winners Of 11th Annual Killer Content Awards

Retrieved on: 
Monday, March 14, 2022
Other Professional Services, Other Communications, Search Engine Marketing, Publishing, Marketing, Advertising, Communications, Professional Services, 2012 Kids' Choice Awards, Editorial, B2B, KCAS, Marketing, ADP, Demand

Demand Gen Report has unveiled the winners of its 11th annual Killer Content Awards (KCAs).

Key Points: 
  • Demand Gen Report has unveiled the winners of its 11th annual Killer Content Awards (KCAs).
  • Since 2012, the KCAs have spotlighted B2B brands that are pushing creative limits and embracing new storytelling methods, formats and campaign strategies to better engage audiences through their content.
  • Every year, our Killer Content Awards nominees prove that B2B content doesnt have to be boring, said Klaudia Tirico, Editor of Demand Gen Report and coordinator of the KCAs.
  • This years finalists and winners truly set the bar for creative storytelling that stands out in this overly saturated digital-first world.

Flow Cytometry Services Market Expected to Reach $ 1.5 Billion by 2030 - InsightAce Analytic Pvt. Ltd.

Retrieved on: 
Wednesday, March 2, 2022
Investment, Multiple myeloma, Government, LLC, KCAS, Acquisition, HIV, Cell, Diagnosis, Flow cytometry, Leukemia, NeoGenomics, Awareness, Solution, Drug development, US, Company, Cancer, Lymphoma, Transport, Becton, Infection, Becton, Dickinson and Company headquarters, BD, Science, GraphPad Software, Efficiency, Laboratory, Research, LabArchives, Charles River Laboratories, Bio-Rad Laboratories, Data analysis, Protein, CAGR, Glossary of biology, AIDS, Antibody, Fine chemical, Medical imaging, Unilab, Fluorescence

According to the latest research by InsightAce Analytic, the global Flow Cytometry Services market is valued at US$ 876.33 Million in 2021, and it is expected to reach US$ 1,501.02 Million by 2030, with a CAGR of 6.21% during the forecast period of 2022-2030.

Key Points: 
  • According to the latest research by InsightAce Analytic, the global Flow Cytometry Services market is valued at US$ 876.33 Million in 2021, and it is expected to reach US$ 1,501.02 Million by 2030, with a CAGR of 6.21% during the forecast period of 2022-2030.
  • Flow cytometry is an effective laboratory technique used to analyze the cell population in heterogenous suspension based on their physical and fluorescence characteristics.
  • Flow Cytometry services consist of specimen processing, experimental design, acquisition and data analysis to strengthen biotech, pharmaceutical companies and researchers in drug development.
  • Curious about Report Details @ Request for ToC/Proposal: https://www.insightaceanalytic.com/report/global-flow-cytometry-services...
    Global Flow Cytometry Services Market, by Accreditation Types, 2019-2030 (Value US$ Mn)
    Global Flow Cytometry Services Market, by Services Types, 2019-2030 (Value US$ Mn)

Flow Cytometry Services Market Expected to Reach $ 1.5 Billion by 2030 - InsightAce Analytic Pvt. Ltd.

Retrieved on: 
Wednesday, March 2, 2022
Investment, Multiple myeloma, Government, LLC, KCAS, Acquisition, HIV, Cell, Diagnosis, Flow cytometry, Leukemia, NeoGenomics, Awareness, Solution, Drug development, US, Company, Cancer, Lymphoma, Transport, Becton, Infection, Becton, Dickinson and Company headquarters, BD, Science, GraphPad Software, Efficiency, Laboratory, Research, LabArchives, Charles River Laboratories, Bio-Rad Laboratories, Data analysis, Protein, CAGR, Glossary of biology, AIDS, Antibody, Fine chemical, Medical imaging, Unilab, Fluorescence

According to the latest research by InsightAce Analytic, the global Flow Cytometry Services market is valued at US$ 876.33 Million in 2021, and it is expected to reach US$ 1,501.02 Million by 2030, with a CAGR of 6.21% during the forecast period of 2022-2030.

Key Points: 
  • According to the latest research by InsightAce Analytic, the global Flow Cytometry Services market is valued at US$ 876.33 Million in 2021, and it is expected to reach US$ 1,501.02 Million by 2030, with a CAGR of 6.21% during the forecast period of 2022-2030.
  • Flow cytometry is an effective laboratory technique used to analyze the cell population in heterogenous suspension based on their physical and fluorescence characteristics.
  • Flow Cytometry services consist of specimen processing, experimental design, acquisition and data analysis to strengthen biotech, pharmaceutical companies and researchers in drug development.
  • Curious about Report Details @ Request for ToC/Proposal: https://www.insightaceanalytic.com/report/global-flow-cytometry-services...
    Global Flow Cytometry Services Market, by Accreditation Types, 2019-2030 (Value US$ Mn)
    Global Flow Cytometry Services Market, by Services Types, 2019-2030 (Value US$ Mn)

KCAS Bioanalytical and Biomarker Services, a Vitruvian Partners portfolio Company, announces acquisition of FlowMetric, LLC

Retrieved on: 
Thursday, February 3, 2022
Data Management, Health, Technology, Research, Science, Pharmaceutical, Biotechnology, Growth, CEO, LLC, Flow cytometry, Contract research organization, Partner, GLP, Partnership, Vitruvian Partners, Acquisition, KCAS, Investment, Drug development, Foundation, Polsinelli, Fine chemical, Financial services, Vitruvian Man, Kansas City metropolitan area, KCAS, FlowMetric –, Vitruvian, KCAS, FLOWMETRIC –, VITRUVIAN

KCAS is a leading U.S.-based Contract Research Organization providing comprehensive GLP-compliant bioanalytical and biomarker development testing services for the biotech, pharmaceutical, and cell/gene therapy industries.

Key Points: 
  • KCAS is a leading U.S.-based Contract Research Organization providing comprehensive GLP-compliant bioanalytical and biomarker development testing services for the biotech, pharmaceutical, and cell/gene therapy industries.
  • Vitruvian Partners , one of the worlds leading growth-focused investment firms, acquired KCAS in April 2021.
  • Sophie Bower-Straziota, Partner at Vitruvian Partners , comments, FlowMetric has built a very strong reputation in flow cytometry services.
  • About KCAS - KCAS Bioanalytical and Biomarker Services is a rapidly growing company that provides comprehensive GLP compliant development services from early discovery support through product registration and beyond.

KCAS Bioanalytical and Biomarker Services Welcomes Dr. Greg Veltri as Scientific Director of Biopharmaceutical Services

Retrieved on: 
Monday, July 12, 2021
Biotechnology, Health, Science, Pharmaceutical, Research, Life sciences, Biology, Articles, Integris Health, KCAS, Biomarker, Contract research organization, Veltri

KCAS Bioanalytical and Biomarker Services (KCAS), a laboratory services focused contract research organization (CRO) is pleased to announce the expansion of their Biopharmaceutical Services team.

Key Points: 
  • KCAS Bioanalytical and Biomarker Services (KCAS), a laboratory services focused contract research organization (CRO) is pleased to announce the expansion of their Biopharmaceutical Services team.
  • Dr. Greg Veltri joins KCAS as a Scientific Director of Cell Based Development Technologies.
  • Dr. Veltri joins KCAS from Sony Biotechnology, based in Bothell, Washington, where he was the Head of Biological Sciences.
  • KCAS Bioanalytical and Biomarker Services, an Integris BioServices, LLC Company is a rapidly growing company that provides comprehensive GLP / GCP compliant development services from early discovery support through product registration and beyond.

KCAS Bioanalytical and Biomarker Services Announces Expansion of Biopharma Leadership, Including John Pirro

Retrieved on: 
Wednesday, June 2, 2021
Biotechnology, Pharmaceutical, Health, KCAS

KCAS Bioanalytical and Biomarker Services, a leading bioanalytical services laboratory, is pleased to announce the expansion of leadership for the Biopharmaceutical Services team.

Key Points: 
  • KCAS Bioanalytical and Biomarker Services, a leading bioanalytical services laboratory, is pleased to announce the expansion of leadership for the Biopharmaceutical Services team.
  • John Pirro, an industry-recognized leader, joined KCAS as a Senior Director of Biopharmaceutical Services to drive growth and expand the technical breadth of the organizations BioPharma Services.
  • John Pirro has been instrumental in providing the Biopharmaceutical Services groups technical leadership, vision for continued growth and scientific expertise to advance KCAS investments into this rapidly growing area of outsourced drug development.
  • Pirros expertise in advanced immunogenicity technical platforms, scientific acumen, and CRO organizational development capabilities has provided the platform for the BioPharma services expansion at KCAS.

Vitruvian Partners announces strategic growth investment in KCAS Bioanalytical and Biomarker Services

Retrieved on: 
Thursday, April 15, 2021
Health, Communications, Other Science, General Health, Research, Science, Public relations, Investor relations, Vitruvian Partners, KCAS, Integris Health, Polsinelli, Service companies, KCAS -, Vitruvian -, Konza Valley Capital Inc. (KVCI) -

b'Vitruvian Partners , one of the world\xe2\x80\x99s leading growth-focused investment firms, announced that it has acquired a majority ownership stake in KCAS Bioanalytical and Biomarker Services (KCAS), located in the Kansas City, Kansas metropolitan area.

Key Points: 
  • b'Vitruvian Partners , one of the world\xe2\x80\x99s leading growth-focused investment firms, announced that it has acquired a majority ownership stake in KCAS Bioanalytical and Biomarker Services (KCAS), located in the Kansas City, Kansas metropolitan area.
  • The company offers a complete range of bioanalytical services from early discovery support through registration, providing expertise in biological (large molecule) and synthetic (small molecule) drug candidates.
  • KVCI and KCAS were advised by BroadOak Capital and Polsinelli.\nAbout KCAS - KCAS Bioanalytical and Biomarker Services, an Integris BioServices, LLC company is a rapidly growing company that provides comprehensive GLP compliant development services from early discovery support through product registration and beyond.
  • Further information regarding KCAS can be found at www.KCASBio.com .\nAbout Vitruvian - Vitruvian is a leading international growth investor headquartered in London with offices in London, Stockholm, Munich, Luxembourg, San Francisco and Shanghai.

Demand Gen Report Announces Winners Of 9th Annual Killer Content Awards

Retrieved on: 
Wednesday, March 4, 2020
KCAS

HASBROUCK HEIGHTS, N.J., March 04, 2020 (GLOBE NEWSWIRE) -- Demand Gen Report has unveiled the winners of its ninth annual Killer Content Awards (KCAs) .

Key Points: 
  • HASBROUCK HEIGHTS, N.J., March 04, 2020 (GLOBE NEWSWIRE) -- Demand Gen Report has unveiled the winners of its ninth annual Killer Content Awards (KCAs) .
  • Since 2012, the KCAs have spotlighted B2B brands that are pushing creative limits, embracing new storytelling methods, formats and campaign strategies, to better engage audiences through their content.
  • As far as the judging process goes, this year was perhaps the most difficult year to date, noted Alicia Esposito, Senior Content Strategist of Demand Gen Report and coordinator of the KCAs.
  • The company put visitors in charge of the journey, allowing them to customize their experience to their wants and needs.